Akums Drugs and Pharmaceuticals Limited (BOM:544222)
India · Delayed Price · Currency is INR 603.70
+2.25 (0.37%)
At close: Jun 19, 2026
BOM:544222 Stock Forecast
Stock Price Forecast
According to 3 analysts polled by S&P Global, BOM:544222 stock has a consensus rating of "Strong Buy" and an average price target of ₹690.00. The average 1-year stock price forecast is 14.30% higher than the current stock price, while the lowest is ₹610.00 (+1.04%) and the highest is ₹780.00 (+29.20%).
Price Target: ₹690.00 (+14.30%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for BOM:544222 stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 3 | 3 | 3 |
Financial Forecast
Revenue This Year
49.41B
from 43.59B
Increased by 13.36%
Revenue Next Year
56.45B
from 49.41B
Increased by 14.24%
EPS This Year
23.45
from 17.55
Increased by 33.64%
EPS Next Year
31.46
from 23.45
Increased by 34.14%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is INR.
Revenue Forecast
| Revenue | 2027 | 2028 | 2029 |
|---|---|---|---|
| High | 49.6B | ||
| Avg | 49.4B | ||
| Low | 49.2B |
Revenue Growth
| Revenue Growth | 2027 | 2028 | 2029 |
|---|---|---|---|
| High | 13.8% | ||
| Avg | 13.4% | ||
| Low | 12.9% |
EPS Forecast
| EPS | 2027 | 2028 | 2029 |
|---|---|---|---|
| High | - | ||
| Avg | 23.45 | ||
| Low | - |
EPS Growth
| EPS Growth | 2027 | 2028 | 2029 |
|---|---|---|---|
| High | - | ||
| Avg | 33.6% | ||
| Low | - |